Grace Therapeutics, Inc. - GRCE
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Sep 10, 2026 | — | P | A | 5,836.0 | 2.0899 | 12,196.66 | 2,775,229.0 | View | |
| Sep 10, 2026 | — | P | A | 9,393.0 | 2.0972 | 19,699.0 | 2,769,393.0 | View | |
| Sep 10, 2026 | Chief Executive Officer | P | A | 100,000.0 | 2.14 | 214,000.0 | 121,357.0 | View | |
| Sep 01, 2026 | VP Program Management | A | A | 35,760.0 | 0.0 | 0.0 | 35,760.0 | View | |
| Sep 01, 2026 | Chief Executive Officer | A | A | 267,160.0 | 0.0 | 0.0 | 267,160.0 | View | |
| Sep 01, 2026 | Chief Medical Officer | A | A | 54,690.0 | 0.0 | 0.0 | 54,690.0 | View | |
| Sep 01, 2026 | Principal Financial Officer | A | A | 33,660.0 | 0.0 | 0.0 | 33,660.0 | View | |
| Aug 19, 2026 | — | P | A | 11,608.0 | 2.0853 | 24,206.16 | 2,760,000.0 | View |